| Unique ID issued by UMIN | UMIN000060020 |
|---|---|
| Receipt number | R000068646 |
| Scientific Title | Reproducibility and clinical validity of liver stiffness measurement using EUS-guided shear-wave elastography in patients with steatotic liver disease: an analysis using Baveno VII stratification |
| Date of disclosure of the study information | 2025/12/09 |
| Last modified on | 2025/12/09 06:22:05 |
Reproducibility of liver stiffness measurement using EUS-SWE and its association with a simple platelet count and AST/ALT ratio-based risk stratification in steatotic liver disease: a prospective observational study
HITO-EUS-SWE
Reproducibility and clinical validity of liver stiffness measurement using EUS-guided shear-wave elastography in patients with steatotic liver disease: an analysis using Baveno VII stratification
HITO-EUS-SWE-SLD
| Japan |
steatotic liver disease (SLD)
| Hepato-biliary-pancreatic medicine |
Others
NO
To evaluate the reproducibility (primary) and clinical validity (secondary) of liver stiffness (kPa) measured by EUS-SWE in patients with steatotic liver disease (SLD), including MASLD/MetALD/ALD. Clinical validity will be assessed by its association with a Baveno VII-referenced alternative stratification based on platelet count (PLT) and the AST/ALT ratio (AAR) (PLT-AAR).
Safety,Efficacy
intra-operator reproducibility assessed using ICC and Bland-Altman analysis (mean difference and 95% limits of agreement)
Clinical validity assessed by AUROC for PLT-AAR stratification with sensitivity, specificity, and optimal thresholds; correlations with PLT, AAR, FIB-4; and feasibility/quality metrics including IQR/median, success rate, procedure time, and complications.
Observational
| 20 | years-old | <= |
| Not applicable |
Male and Female
Inclusion criteria: (1) Adults aged 20 years and older clinically diagnosed with SLD (MASLD/MetALD/ALD) scheduled to undergo EUS as part of routine care; (2) ability to provide written informed consent.
Exclusion criteria: conditions judged unsuitable for EUS (e.g., severe general condition, high bleeding risk), pregnancy or suspected pregnancy, comorbidities or cognitive impairment interfering with participation, or any other reason deemed inappropriate by the principal investigator.
100
| 1st name | Takako |
| Middle name | |
| Last name | Nomura |
HITO Medical Center
Department of Gastroenterology and Hepatology
7990121
788-1, Kamibun-Cho, Shikokutyuou-city, Ehime, Japan
0896582222
nomura.takako@hito-medical.net
| 1st name | Takako |
| Middle name | |
| Last name | Nomura |
HITO Medical Center
Department of Gastroenterology and Hepatology
7990121
788-1, Kamibun-Cho, Shikokutyuou-city, Ehime, Japan
0896582222
nomura.takako@hito-medical.net
HITO Medical Center
HITO Medical Center
Other
HITO Medical Center
788-1, Kamibun-Cho, Shikokutyuou-city, Ehime, Japan
0896582222
nomura.takako@hito-medical.net
NO
| 2025 | Year | 12 | Month | 09 | Day |
Unpublished
Preinitiation
| 2025 | Year | 12 | Month | 01 | Day |
| 2025 | Year | 12 | Month | 09 | Day |
| 2029 | Year | 03 | Month | 31 | Day |
This is a prospective non-interventional observational study in which EUS-SWE liver stiffness measurements will be additionally obtained within clinically indicated EUS and analyzed. No new treatment or drug administration is involved. The main study-related burden is an approximately 3-minute extension of the examination time. Data will be managed using linkable anonymization. The study is funded by departmental research funds without industry funding or device provision. The study outline will be registered and publicly available in UMIN-CTR.
| 2025 | Year | 12 | Month | 09 | Day |
| 2025 | Year | 12 | Month | 09 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000068646